Status:

UNKNOWN

Study to Investigate the Effectiveness of a Food Supplement Made of Hop in the Improvement of Menopausal Symptoms

Lead Sponsor:

Aristo Pharma Iberia

Collaborating Sponsors:

Analysis and Research Network, S.L

Conditions:

Menopause

Eligibility:

FEMALE

40-60 years

Brief Summary

This observational study will assess the effects of a dietary supplement based on Humulus Lupulus L. to relieve the symptoms of menopause in perimenopausal and postmenopausal women, by doing a follow ...

Eligibility Criteria

Inclusion

  • Perimenopausal according to the Stages of Reproductive Aging Workshop (STRAW) or postmenopausal women between the ages of 40 and 60.
  • Having moderate or severe hot flushes.
  • Accepting and signing the Informed consent.

Exclusion

  • Women unable to answer the questionnaires.
  • Women being treated with sulfonamides, methotrexate, triamterene, sulfasalazine, estrogens, phenytoin, anxiolytics, antidepressants, daily multivitamins, hormonal therapy, use of oral contraceptives in the last 3 months, herbal products to reduce vasomotor symptoms in the last months.
  • Women in treatment and control for psychiatric pathology.
  • Women with any comorbidity that could be the cause of a symptomatology coinciding but not bound to peri or post-menopause.
  • Women diagnosed or with Clinical suspicion of breast cancer, endometrium or other hormone-dependent tumors, genital tract bleeding, actives thromboembolic disorders, active gall bladder illness or being lactose intolerant.
  • Women being treated with antithyroid medications and other drugs like letrozole, raloxifene, bazedoxifene, bethanechol, desmopressin and calcitonin or other drugs that at investigators judgement could interfere in the study's result.
  • Use of dietary supplements that include phytoestrogens (drinks or desserts based in soya) in the last month.
  • Women with coronary diseases, strokes or chronic renal diseases, type 2 diabetes, deep vein thrombosis or pulmonary embolism.

Key Trial Info

Start Date :

April 15 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 30 2019

Estimated Enrollment :

443 Patients enrolled

Trial Details

Trial ID

NCT03875430

Start Date

April 15 2019

End Date

October 30 2019

Last Update

March 14 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.